Proceedings 2017, 1(6), 699; doi:10.3390/proceedings1060669 (registering DOI)
Current Pipeline of Antimalarial Therapies†
Medicines for Malaria Venture (MMV), 1215 Geneva, Switzerland
Presented at the 1st Molecules Medicinal Chemistry Symposium, Barcelona, Spain, 8 September 2017.
Published: 18 October 2017
Note: In lieu of an abstract, this is an excerpt from the first page.
Malaria is a devastating disease affecting millions of people each year yet, surprisingly, apart from the Artemisinin Combination Therapies (ACTs) there are relatively few effective treatments for Plasmodium falciparum
and only one complete treatment for Plasmodium vivax
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Scifeed alert for new publications
Never miss any articles
matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
Define your Scifeed now
Share & Cite This Article
MDPI and ACS Style
Laleu, B. Current Pipeline of Antimalarial Therapies. Proceedings 2017, 1, 699.
Laleu B. Current Pipeline of Antimalarial Therapies. Proceedings. 2017; 1(6):699.
Laleu, Benoît. 2017. "Current Pipeline of Antimalarial Therapies." Proceedings 1, no. 6: 699.
Show more citation formats
Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
[Return to top]
Multiple requests from the same IP address are counted as one view.